Valuation: WuXi XDC Cayman Inc.

Capitalization 75.42B 83.21B 10.69B 9.11B 8.51B 8B 14.74B 968B 16.1B 99.29B 38.52B 456B 40.11B 39.27B 1,665B P/E ratio 2025 *
47.1x
P/E ratio 2026 * 34.2x
Enterprise value 72.53B 80.02B 10.28B 8.76B 8.18B 7.7B 14.17B 931B 15.48B 95.48B 37.04B 439B 38.57B 37.76B 1,601B EV / Sales 2025 *
12.1x
EV / Sales 2026 * 8.9x
Free-Float
19.62%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-6.09%
1 week-1.78%
Current month+1.30%
1 month-6.36%
3 months-1.70%
6 months+47.99%
Current year+116.31%
More quotes
1 week 66.1
Extreme 66.1
72.8
1 month 62.3
Extreme 62.3
72.8
Current year 24.7
Extreme 24.7
85.5
1 year 24.7
Extreme 24.7
85.5
3 years 12.08
Extreme 12.08
85.5
5 years 12.08
Extreme 12.08
85.5
10 years 12.08
Extreme 12.08
85.5
More quotes
Manager TitleAgeSince
Chief Executive Officer 52 30/11/2020
Director of Finance/CFO 50 30/04/2023
Chief Tech/Sci/R&D Officer 60 31/05/2023
Director TitleAgeSince
Director/Board Member 52 30/11/2020
Director/Board Member 57 31/05/2023
Director/Board Member 50 31/05/2023
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-6.09%-1.78%+112.50% - 10.69B
+1.80%+1.70%+30.21%+186.49% 920B
+0.75%+4.78%+44.31%+18.06% 510B
-0.29%-1.22%+28.81%+35.52% 395B
-0.35%+1.90%+25.12%+3.11% 340B
-1.12%-1.09%+28.43%+18.70% 278B
-0.45%-1.48%+20.24%+24.41% 254B
+1.30%+0.58%-1.67%-9.57% 249B
+0.45%+3.73%-57.41%-30.85% 224B
+0.11%-3.68%+17.41%+16.70% 171B
Average -0.39%+0.37%+24.80%+29.18% 335.27B
Weighted average by Cap. +0.52%+1.14%+22.15%+60.09%
See all sector performances

Financials

2025 *2026 *
Net sales 6.02B 6.64B 853M 726M 679M 638M 1.18B 77.23B 1.28B 7.92B 3.07B 36.4B 3.2B 3.13B 133B 8.06B 8.9B 1.14B 974M 910M 856M 1.58B 104B 1.72B 10.62B 4.12B 48.8B 4.29B 4.2B 178B
Net income 1.57B 1.73B 222M 190M 177M 167M 307M 20.15B 335M 2.07B 802M 9.5B 835M 817M 34.66B 2.12B 2.33B 300M 255M 239M 224M 413M 27.16B 451M 2.78B 1.08B 12.8B 1.12B 1.1B 46.7B
Net Debt -2.89B -3.19B -410M -349M -326M -307M -565M -37.14B -618M -3.81B -1.48B -17.51B -1.54B -1.51B -63.87B -3.63B -4B -514M -438M -409M -385M -709M -46.57B -774M -4.78B -1.85B -21.95B -1.93B -1.89B -80.1B
More financial data * Estimated data
Logo WuXi XDC Cayman Inc.
WuXi XDC Cayman Inc is an investment holding company principally engaged in the provision of comprehensive contract research, development and manufacturing organization (CRDMO) services for antibody drug conjugate (ADC) and other bioconjugates. The Company's services include the discovery, process development and Good Manufacturing Practice (GMP) manufacturing for bioconjugates, monoclonal antibody intermediates and payload-linkers associated with bioconjugates. The Company provides CRDMO services to customers through contracts under fee-for-service (FFS) basis and contracts under full-time equivalent (FTE) basis. The Company principally conducts its businesses in domestic and overseas markets, including North America, Europe and the rest of the world.
Employees
2,270
More about the company
Date Price Change Volume
12/12/25 66.30 $ -6.09% 9,612,217
11/12/25 70.60 $ +0.14% 5,085,944
10/12/25 70.50 $ +1.29% 4,262,438
09/12/25 69.60 $ +3.34% 6,797,230
08/12/25 67.35 $ -0.22% 2,095,199

End-of-day quote Hong Kong S.E., December 11, 2025

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
60.09CNY
Average target price
72.28CNY
Spread / Average Target
+20.29%
Consensus

Quarterly revenue - Rate of surprise